Thiamine-Responsive Megaloblastic Anemia Syndrome: Long Term Follow-Up

Journal of Pediatrics

Volumn 155, Issue 2, 2009, Pages 295-297

  Borgna Pignatti, Caterina ^a   Azzalli, Milena ^a   Pedretti, Stefania ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; THIAMINE;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIABETES MELLITUS; DRUG DOSE INCREASE; FEMALE; HUMAN; LONG TERM CARE; MEGALOBLASTIC ANEMIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANEMIA, MEGALOBLASTIC; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; THIAMINE; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 67651094112     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.01.062     Document Type: Article

References (15)

1. Lagarde W.H., Underwood L.E., Moats-Staats B.M., and Calikoglu A.S. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive anemia syndrome. Am J Med Genetics 125A (2004) 299-305
2. Orphanet Report Series. Prevalence of rare diseases: bibliographic data. Aug 2008 (9). Available at http://www.orpha.net/orphacom/cahiers/docs
3. Borgna-Pignatti C., Marradi P., Pinelli L., Monetti N., and Patrini C. Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr 114 (1989) 405-410
4. Neufeld E.J., Mandel H., Raz T., Szargel R., Yandava C.N., Stagg A., et al. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet 61 (1997) 1335-1341
5. Inoue H., Tanizawa Y., Wasson J., Behn P., Kalidas K., Bernal-Mizrachi E., et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20 (1998) 143-148
6. Labay V., Raz T., Baron D., Mandel H., Williams H., Barrett T., et al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anemia associated with diabetes mellitus and deafness. Nat Genet 22 (1999) 300-304
7. Subramanian V.S., Marchant J.S., and Said H.M. Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines. Clin Sci(Lond) 113 (2007) 93-102
8. Yesilkaya E., Bideci A., Temizkan M., Kaya Z., Camurdan O., Koç A., et al. A novel mutation in the SLC19A2 gene in a turkish female with thiamine-responsive megaloblastic anemia syndrome. J Trop Pediatr (2008 Jul 9) [Epub ahead of print]
9. Baron D., Assaraf Y.G., Cohen N., and Aronheim A. Lack of plasma membrane targeting of G172D mutant thiamine transporter derived from Rogers syndrome family. Mol Med 8 (2002) 462-474
10. Oishi K., Hofmann S., Diaz G.A., Brown T., Manwani D., Ng L., et al. Targeted disruption of SLC19A2, the gene encoding the high affinity thiamine transporter THTR-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum Mol Genet 11 (2002) 2951-2960
11. Ricketts C.J., Minton J.A., Samuel J., Ariyawansa I., Wales J.K., Lo I.F., et al. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr 95 (2006) 99-104
12. Valerio G., Franzese A., Poggi V., and Tenore A. Long-term follow-up of diabetes in two patients with TRMA syndrome. Diabetes Care 21 (1998) 38-41
13. Liberman M.C., Tartaglini E., Fleming J.C., and Neufeld E.J. Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. J Assoc Res Otolaryngol 7 (2006) 211-217
14. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) on a request from the Commission on benfotiamine, thiamine monophosphate chloride and thiamine pyrophosphate chloride, as sources of vitamin B1. EFSA J 864 (2008) 1-31
15. Meire F.M., Van Genderen M.M., Lemmens K., and Ens-Dokkum M.H. Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy. Ophtalmic Genet 21 (2000) 243-250